EUVIMEDEUVIMED entdecken
Crossref

KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma

Toru Motoi, Makoto Hirata, Yoji Kukita, Kaishi Satomi, Hiromi Tamura, Shiro Adachi, Yuko Matsushita, Shin-Ichiro Horiguchi, Tsunekazu Hishima, Masachika Ikegami, Tomotake Okuma, Kayoko Tao und 7 weitere

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2023.100317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Toru Motoi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. Electronic address: tmotoi-tky@umi…. Hauptthemen laut MEDLINE: Sarcoma, Sarcoma, Synovial, Soft Tissue Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: AMED, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcomas with BCOR genetic alterations (BCOR-associated sarcomas) represent a recently recognized family of soft tissue and bone tumors characterized by BCOR fusion, BCOR internal tandem duplication, or YWHAE::NUTM2B fusion. Histologically, the tumors demonstrate oval to spindle cell proliferation in a variably vascular stroma and overexpression of BCOR and SATB2. Herein, we describe 3 soft tissue sarcomas with KDM2B fusions that phenotypically and epigenetically match BCOR-associated sarcomas. The cases included 1 infant, 1 adolescent, and 1 older patient. All tumors showed histologic findings indistinguishable from those of BCOR-associated sarcomas and were originally diagnosed as such based on the phenotype. However, none of the tumors had BCOR or YWHAE genetic alterations. Instead, targeted RNA sequencing identified in-frame KDM2B::NUTM2B, KDM2B::CREBBP, and KDM2B::DUX4 fusions. KDM2B fusions were validated using reverse-transcription PCR, Sanger sequencing, and in situ hybridization assays. Genome-wide DNA methylation analysis matched all 3 tumors with BCOR-associated sarcomas using the Deutsches Krebsforschungszentrum (DKFZ) classifier and t-distributed stochastic neighbor embedding analysis. One localized tumor showed a flat genome-wide copy number profile, and the patient remained disease-free after treatment. The other tumors showed multiple copy number alterations, including MDM2/CDK4 amplification and/or CDKN2A/B loss, and both tumors metastasized, leading to the patient's death in one of the cases. When tested using KDM2B immunohistochemistry, all 3 KDM2B-rearranged sarcomas showed diffuse strong staining, and all 13 sarcomas with BCOR genetic alterations also demonstrated diffuse, strong, or weak staining. By contrast, among 72 mimicking tumors, only a subset of synovial sarcomas showed focal or diffuse weak KDM2B expression. In conclusion, our study suggests that KDM2B-rearranged soft tissue sarcomas belong to the BCOR-associated sarcoma family and expand its molecular spectrum. This may be related to the known molecular relationship between KDM2B and BCOR in the polycomb repressive complex 1.1. Immunohistochemical analysis of KDM2B is a potentially valuable diagnostic tool for BCOR-associated sarcomas, including those with KDM2B rearrangement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaSarcoma, SynovialSoft Tissue NeoplasmsInfantAdolescentHumansRepressor ProteinsTranscription FactorsPolymerase Chain ReactionBiomarkers, TumorProto-Oncogene Proteins

Stichwörter der Autor:innen

BCORKDM2BPRC1.1fusion genesarcoma

Substanzen

Repressor ProteinsTranscription FactorsBiomarkers, TumorBCOR protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. Electronic address: tmotoi-tky@umin.ac.jp.
  • Laboratory of Genome Technology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan; Department of Pathology, Kyorin University Faculty of Medicine, Tokyo, Japan.
  • Department of Pathology, Toyonaka Municipal Hospital, Osaka, Japan.
  • Department of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Förderung

  • AMED
  • Japan Society for the Promotion of Science

Zitieren

APA

Motoi, T., Hirata, M., Kukita, Y., Satomi, K., Tamura, H., Adachi, S., Matsushita, Y., Horiguchi, S. I., Hishima, T., Ikegami, M., Okuma, T., Tao, K., Arakawa, A., Ogawa, C., Matsuda, K., Ichimura, K., Nakamura, H., Mori, T., & Yoshida, A. (2023). KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100317

Vancouver

Motoi T, Hirata M, Kukita Y, Satomi K, Tamura H, Adachi S, et al. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100317

BibTeX
@article{Motoi2023,
  author = {Motoi, Toru and Hirata, Makoto and Kukita, Yoji and Satomi, Kaishi and Tamura, Hiromi and Adachi, Shiro and Matsushita, Yuko and Horiguchi, Shin-Ichiro and Hishima, Tsunekazu and Ikegami, Masachika and Okuma, Tomotake and Tao, Kayoko and Arakawa, Ayumu and Ogawa, Chitose and Matsuda, Koichi and Ichimura, Koichi and Nakamura, Harumi and Mori, Taisuke and Yoshida, Akihiko},
  title = {KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2023.100317}
}
Kostenlos starten →